Literature DB >> 18395371

Immunochemical assessment of deoxynivalenol tissue distribution following oral exposure in the mouse.

James J Pestka1, Zahidul Islam, Chidozie J Amuzie.   

Abstract

Deoxynivalenol (DON or vomitoxin) is a trichothecene mycotoxin commonly found in cereal grains that adversely affects growth and immune function in experimental animals. A competitive enzyme-linked immunosorbent assay (ELISA) was used to monitor the kinetics of distribution and clearance of DON in tissues of young adult B6C3F1 male mice that were orally administered 25mg/kg bw of the toxin. DON was detectable from 5 min to 24h in plasma, liver, spleen and brain and from 5 min to 8h in heart and kidney. The highest DON plasma concentrations were observed within 5-15 min (12 microg/mL) after dosing. There was rapid clearance following two-compartment kinetics (t(1/2)alpha=20.4 min, t 1/2 beta=11.8h) with 5% and 2% maximum plasma DON concentrations remaining after 8 and 24h, respectively. DON distribution and clearance kinetics in other tissues were similar to that of plasma. At 5 min, DON concentrations in mug/g were 19.5+/-1.9 in liver, 7.6+/-0.5 in kidney, 7.3+/-0.8 in spleen, 6.8+/-0.9 in heart and 0.8+/-0.1 in the brain. DON recoveries in tissues by ELISA were comparable to a previous study that employed (3)H-DON and 25mg/kg bw DON dose. The ELISA was further applicable to the detection of DON in plasma of mice exposed to the toxin via diet. This approach provides a simple strategy that can be used to answer relevant questions in rodents of how dose, species, age, gender, genetic background and route/duration of exposure impact DON uptake and clearance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395371      PMCID: PMC2696392          DOI: 10.1016/j.toxlet.2008.02.005

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  33 in total

1.  Pharmacokinetics of ochratoxin A and its metabolites in rats.

Authors:  S Li; R R Marquardt; A A Frohlich; T G Vitti; G Crow
Journal:  Toxicol Appl Pharmacol       Date:  1997-07       Impact factor: 4.219

Review 2.  The trichothecenes and their biosynthesis.

Authors:  J F Grove
Journal:  Fortschr Chem Org Naturst       Date:  2007

3.  p38 Mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes.

Authors:  Zahidul Islam; Jennifer S Gray; James J Pestka
Journal:  Toxicol Appl Pharmacol       Date:  2005-12-20       Impact factor: 4.219

4.  Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink.

Authors:  A Hem; A J Smith; P Solberg
Journal:  Lab Anim       Date:  1998-10       Impact factor: 2.471

5.  Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): dose response and time course.

Authors:  H R Zhou; D Yan; J J Pestka
Journal:  Toxicol Appl Pharmacol       Date:  1997-06       Impact factor: 4.219

6.  Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck.

Authors:  Hui-Ren Zhou; Qunshan Jia; James J Pestka
Journal:  Toxicol Sci       Date:  2005-03-16       Impact factor: 4.849

Review 7.  Deoxynivalenol: toxicology and potential effects on humans.

Authors:  James J Pestka; Alexa T Smolinski
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2005 Jan-Feb       Impact factor: 6.393

Review 8.  Risk assessment of deoxynivalenol in food: concentration limits, exposure and effects.

Authors:  Moniek N Pieters; Jan Freijer; Bert-Jan Baars; Daniëlle C M Fiolet; Jacob van Klaveren; Wout Slob
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

Review 9.  Assessment factors--applications in health risk assessment of chemicals.

Authors:  Agneta Falk-Filipsson; Annika Hanberg; Katarina Victorin; Margareta Warholm; Maria Wallén
Journal:  Environ Res       Date:  2006-12-12       Impact factor: 6.498

10.  Plasma pharmacokinetics of the mycotoxin deoxynivalenol following oral and intravenous administration to sheep.

Authors:  D B Prelusky; D M Veira; H L Trenholm
Journal:  J Environ Sci Health B       Date:  1985-12       Impact factor: 1.990

View more
  31 in total

1.  Effects of oral deoxynivalenol exposure on immune-related parameters in lymphoid organs and serum of mice vaccinated with porcine parvovirus vaccine.

Authors:  Byung-Kook Choi; Sang-Hee Jeong; Joon-Hyung Cho; Hyo-Sook Shin; Seong-Wan Son; Young-Keun Yeo; Hwan-Goo Kang
Journal:  Mycotoxin Res       Date:  2013-02-24       Impact factor: 3.833

2.  Characterization of deoxynivalenol-induced anorexia using mouse bioassay.

Authors:  Brenna M Flannery; Wenda Wu; James J Pestka
Journal:  Food Chem Toxicol       Date:  2011-05-07       Impact factor: 6.023

3.  Role of cholecystokinin in anorexia induction following oral exposure to the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol.

Authors:  Wenda Wu; Hui-Ren Zhou; Kaiyu He; Xiao Pan; Yoshiko Sugita-Konishi; Maiko Watanabe; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2014-01-02       Impact factor: 4.849

4.  Evaluation of insulin-like growth factor acid-labile subunit as a potential biomarker of effect for deoxynivalenol-induced proinflammatory cytokine expression.

Authors:  Brenna M Flannery; Chidozie J Amuzie; James J Pestka
Journal:  Toxicology       Date:  2013-01-05       Impact factor: 4.221

5.  Comparison of emetic potencies of the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol.

Authors:  Wenda Wu; Melissa A Bates; Steven J Bursian; Jane E Link; Brenna M Flannery; Yoshiko Sugita-Konishi; Maiko Watanabe; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2012-09-20       Impact factor: 4.849

6.  Body composition and hormonal effects following exposure to mycotoxin deoxynivalenol in the high-fat diet-induced obese mouse.

Authors:  Kazuo Kobayashi-Hattori; Chidozie J Amuzie; Brenna M Flannery; James J Pestka
Journal:  Mol Nutr Food Res       Date:  2011-05-02       Impact factor: 5.914

7.  Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).

Authors:  Wenda Wu; Melissa A Bates; Steven J Bursian; Brenna Flannery; Hui-Ren Zhou; Jane E Link; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2013-03-01       Impact factor: 4.849

8.  Deoxynivalenol and its toxicity.

Authors:  Pavlina Sobrova; Vojtech Adam; Anna Vasatkova; Miroslava Beklova; Ladislav Zeman; Rene Kizek
Journal:  Interdiscip Toxicol       Date:  2010-09

9.  Comparison of anorectic and emetic potencies of deoxynivalenol (vomitoxin) to the plant metabolite deoxynivalenol-3-glucoside and synthetic deoxynivalenol derivatives EN139528 and EN139544.

Authors:  Wenda Wu; Hui-Ren Zhou; Steven J Bursian; Xiao Pan; Jane E Link; Franz Berthiller; Gerhard Adam; Anthony Krantis; Tony Durst; James J Pestka
Journal:  Toxicol Sci       Date:  2014-08-30       Impact factor: 4.849

10.  Tissue distribution and proinflammatory cytokine gene expression following acute oral exposure to deoxynivalenol: comparison of weanling and adult mice.

Authors:  James J Pestka; Chidozie J Amuzie
Journal:  Food Chem Toxicol       Date:  2008-07-09       Impact factor: 6.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.